CD63 and neoplasm: CD9+/CD63+/CD81+ EVs (Transport‐EVs) transmit resistance, whereas CD147+/LAMB1+ EVs (Excretion‐EVs) excrete tumour‐suppressive cargos, highlighting the functional divergence of EV subtypes in GCB resistance.